Next Article in Journal
Wetting Properties of Defective Graphene Oxide: A Molecular Simulation Study
Previous Article in Journal
Recent Advances in Applications of Ionic Liquids in Miniaturized Microextraction Techniques
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Sun, Y.; et al. Design, Synthesis, and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors. Molecules 2017, 22, 1739

1
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an 710069, China
2
Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of the Ministry of Education, College of Chemistry 0026 Materials Science, Northwest University, Xi’an 710127, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this paper.
Molecules 2018, 23(6), 1438; https://doi.org/10.3390/molecules23061438
Submission received: 29 May 2018 / Revised: 30 May 2018 / Accepted: 31 May 2018 / Published: 13 June 2018
The author wishes to make the following corrections to this paper [1]. Due to our oversight, the title of article [1] was same as that of article [2]. Because our research ideas and methods were different from those of article [2], we did not list it as a reference study in the article [1]. We would like to offer our sincere apologies to all of the authors of the article [2], who were Addla Dinesh, Jallapally Anvesh, Kanwal Abhinav, Sridhar Balasubramanian, Banerjee Sanjay K., and Kantevari Srinivas.
The corrections include: (1) replacing the title “Design, Synthesis, and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors” with “Design, Synthesis, and Evaluation of Novel Phenolic acid/Dipeptide/Borneol Hybrids as Potent Angiotensin Converting Enzyme (ACE) Inhibitors with Anti-hypertension Activity”; and (2) replacing “2-hydroxypyrrolobenzodiazepine-5,11-dione analogues” with “phenolic acid/dipeptide/borneol hybrids” in the abstract.
The authors would like to apologize for any inconvenience caused to the readers by these changes.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sun, Y.; Bai, Y.; He, X.; Bai, Y.; Liu, P.; Zhao, Z.; Chen, X.; Zheng, X. Design, Synthesis and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors. Molecules 2017, 22, 1739. [Google Scholar] [CrossRef] [PubMed]
  2. Addla, D.; Jallapally, A.; Kanwal, A.; Sridhar, B.; Banerjee, S.K.; Kantevari, S. Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors. Bioorg. Med. Chem. 2013, 21, 4485–4493. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Sun, Y.; Bai, Y.; He, X.; Bai, Y.; Liu, P.; Zhao, Z.; Chen, X.; Zheng, X. Correction: Sun, Y.; et al. Design, Synthesis, and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors. Molecules 2017, 22, 1739. Molecules 2018, 23, 1438. https://doi.org/10.3390/molecules23061438

AMA Style

Sun Y, Bai Y, He X, Bai Y, Liu P, Zhao Z, Chen X, Zheng X. Correction: Sun, Y.; et al. Design, Synthesis, and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors. Molecules 2017, 22, 1739. Molecules. 2018; 23(6):1438. https://doi.org/10.3390/molecules23061438

Chicago/Turabian Style

Sun, Ying, Yujun Bai, Xirui He, Yajun Bai, Pei Liu, Zefeng Zhao, Xufei Chen, and Xiaohui Zheng. 2018. "Correction: Sun, Y.; et al. Design, Synthesis, and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors. Molecules 2017, 22, 1739" Molecules 23, no. 6: 1438. https://doi.org/10.3390/molecules23061438

Article Metrics

Back to TopTop